GSK plc
GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$48.58−0.66 (-1.34%)
Close on Nov 18, 2026Market cap $104.82BP/E 13.2Yield –
GSK Intangible Asset & R&D Partner Milestone Commitments by Year
GSK Intangible Asset & R&D Partner Milestone Commitments: 17,048.00 £M in FY2025, down 11.1% from a year earlier.
Latest, FY2025
17,048.00
Period ended Dec 31, 2025
Change on a year earlier
-11.1%
19,183.00 in FY2024
History
6 years
Since FY2020
Sources
5
Documents cited below
Where the FY2025 figure comes from
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Intangible Asset & R&D Partner Milestone Commitments | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17,048.00 | -11.1% | GSK Form 20-F (FY2025, Inline XBRL) ↗ |
| FY2024 | Dec 31, 2024 | 19,183.00 | +17.5% | GSK Form 20-F (FY2025, Inline XBRL) ↗ |
| FY2023 | Dec 31, 2023 | 16,329.00 | +53.2% | GSK Form 20-F (FY2024, Inline XBRL) ↗ |
| FY2022 | Dec 31, 2022 | 10,659.00 | -11.8% | GSK Form 20-F (FY2023, Inline XBRL) ↗ |
| FY2021 | Dec 31, 2021 | 12,082.00 | -1.8% | GSK Form 20-F (FY2022, Inline XBRL) ↗ |
| FY2020 | Dec 31, 2020 | 12,307.00 | – | GSK Form 20-F (FY2021, Inline XBRL) ↗ |
Cite this data
StockData. (2026). GSK Intangible Asset & R&D Partner Milestone Commitments, annual FY2020–FY2025 [Data set]. Compiled from GSK SEC filings and investor materials. https://stockdatahq.com/stocks/gsk/kpis/commit-intangibles-rd
See every metric in the GSK KPI table. Data updated Nov 7, 2026.
See a number that looks wrong?